2012 annual financial data
Seres Therapeutics 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -3,033,000 USD and net income was -3,126,000 USD.
Operating cash flow was -2,925,000 USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -3,033,000 USD
- Net income
- -3,126,000 USD
- Operating cash flow
- -2,925,000 USD